pf-06687252 and Multiple-Myeloma

pf-06687252 has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for pf-06687252 and Multiple-Myeloma

Article	Year
SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic Cancer research, 2021, 05-01, Volume: 81, Issue:9 Topics: Animals; Azabicyclo Compounds; Cell Line, Tumor; Cell Survival; Chromatin Assembly and Disassembly; Female; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Neoplasm Proteins; Protein Tyrosine Phosphatases; Pyridines; Repressor Proteins; Transcription Factors; Transcriptional Activation; Transfection; Translocation, Genetic; Tumor Burden; Xenograft Model Antitumor Assays	2021

Article

Year

SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic

Cancer research, 2021, 05-01, Volume: 81, Issue:9

Topics: Animals; Azabicyclo Compounds; Cell Line, Tumor; Cell Survival; Chromatin Assembly and Disassembly; Female; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Neoplasm Proteins; Protein Tyrosine Phosphatases; Pyridines; Repressor Proteins; Transcription Factors; Transcriptional Activation; Transfection; Translocation, Genetic; Tumor Burden; Xenograft Model Antitumor Assays

2021